U.S. near bottom of wealthy nations in childbirth deaths November 22, 2015
American children with autism may have been undercounted November 14, 2015
Medicare to spend $9 billion on hepatitis C drugs November 14, 2015
What happens after you down an energy drink? November 14, 2015
U.S. adult cigarette smoking hits a new low November 13, 2015
U.S. sees alarming jump in newborns with syphilis November 12, 2015
DNA hunt on as Chipotle E. coli outbreak grows November 3, 2015
Experts urge reassessment of breast cancer screening November 1, 2015
At top hospital, almost half of surgeries have drug mishap October 30, 2015
Study: Want a younger brain? Eat fish, stay away from meat October 25, 2015
The latest hope as a psychiatric rescue drug is called MI-4, and news of its promise was reported this week at the San Diego meeting of the Federation of American Societies for Experimental Biology.
In the test tube, MI-4 was found to simultaneously increase the availability in the brain of three neurotransmitters that play a key role in depression: serotonin, dopamine and norepinephrine. Researchers led by Jeffery N. Talbot of Roseman University of Health Science in Henderson, Nev., found that in mice that had been stressed and trained to expect no rescue from frightening circumstances-a depression-like condition called “learned helplessness”-MI-4 quickly restored more hopeful behavior and continued to do so for three weeks - a lengthy stretch for a mouse.
Compared with a placebo, MI-4 made virtual social butterflies of mice who had been brought low by social defeat, and whose depression manifested as withdrawal. And for a continuous three-week period, it helped fortify those mice against the effects of further social defeat.
MI-4 was found during a “virtual screening,” in which a computer model is used to find agents that act on known targets, in this case, for depression drugs.
“From looking at its structure, one would never have guessed that this drug interacts with the same monoamine transporter proteins as does Paxil or cocaine, but it does. That speaks to the ‘needle in a haystack’ detection power of the virtual screening methodology,” said Christopher Surratt, a professor of pharmacology working on this aspect of the study at Duquesne University.
Ketamine, the anesthesia medication-turned-party drug, has also shown promise as a fast-acting antidepressant but is hobbled by practical drawbacks.
MI-4 appears to have several advantages over ketamine, which, as a drug that induces a sort of out-of-body high when used at higher doses and is, therefore, considered to have abuse potential. Mice taking MI-4 were no more likely to hang out close to the drug-dispenser than they were to wander around and explore and socialize-a clear sign that its abuse or addictive potential is low.
Ketamine also needs to be infused, and in careful doses. While it is highly effective at lifting depression quickly, it’s not easy for a patient to take it home and stay on it for long.
More Nation & World Headlines
Paris attacks rooted in Brussels: Why Belgium? U.S. near bottom of wealthy nations in childbirth deaths Rich and famous to get a private lounge at LAX Armed older couple gets upper hand on burglar Vladimir Putin’s massive, triple-decker war room revealed Louisiana elects Democrat as next governor Iran war game simulates capture of Jerusalem Midwest snow piles up beyond expectations
Our new comment system is not supported in IE 7. Please upgrade your browser here.